Santen Pharmaceutical
9
9M
7
0.07
2
0.22
3
- Areas of investment
Summary
Santen Pharmaceutical is the famous Corporate Investor, which was founded in 1890. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Emeryville.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Santen Pharmaceutical, startups are often financed by Hatteras Venture Partners, GRA Venture Fund, LLC, Tech Coast Angels. The meaningful sponsors for the fund in investment in the same round are Hatteras Venture Partners, Saints Capital, RMI Partners. In the next rounds fund is usually obtained by Virginia Tech Carilion (VTC) Innovation Fund, Pharmstandard, Rock Springs Capital.
The top activity for fund was in 2015. The higher amount of exits for fund were in 2016. The fund is generally included in less than 2 deals every year. This Santen Pharmaceutical works on 21 percentage points more the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. Speaking about the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations.
The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline InnFocus Inc, RetroSense Therapeutics, Clearside Biomedical For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Medical, Therapeutics.
The current fund was established by Kenkichi Taguchi.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 2
- Exits
- 3
- Rounds per year
- 0.07
- Follow on index
- 0.22
- Investments by industry
- Biotechnology (4)
- Medical Device (4)
- Therapeutics (3)
- Medical (3)
- Pharmaceuticals (2) Show 9 more
- Investments by region
-
- United States (6)
- Japan (2)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 8M
- Group Appearance index
- 0.78
- Avg. company exit year
- 10
- Avg. multiplicator
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| InnFocus Inc | 23 Dec 2015 | Biotechnology, Medical Device, Medical | Late Stage Venture | 33M | United States, Florida, Miami |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.